Company: GEHC
Filing Date: 2025-06-05
Form Type: 424B2
Source: 0001193125-25-135863
Chunk: 44

Company: GE HealthCare Technologies Inc.
Filing Date: 2025-06-05
Form: 424B2
Chunk 44
---
, maintain or
otherwise affect the market price of the notes. As a result, the price of the notes may be higher than the price that otherwise might exist in the open market. If these activities are commenced, they may be discontinued by the underwriters at any
time. These transactions may be effected in the over-the-counter market or otherwise.

We estimate that our share of the total expenses of the offering, excluding the underwriting discounts, will be approximately $4 million.

Certain affiliates of the underwriters hold some of the 2025 notes being repaid and, as a result, will receive at least 5% of the net
offering proceeds See “Use of Proceeds.” Accordingly, this offering is being made in compliance with FINRA Rule 5121. In accordance with Rule 5121, the appointment of a qualified independent underwriter is not required since the notes
offered are rated investment grade. The underwriters subject to Rule 5121 will not confirm sales of the notes to discretionary accounts without prior written consent of the customers.

We have agreed to indemnify the several underwriters against certain liabilities, including liabilities under the Securities Act of 1933, as
amended, or under certain circumstances to contribute to payments which the underwriters may be required to make in that respect.

The
underwriters and their respective affiliates are full service financial institutions engaged in various activities, which may include securities trading, commercial and investment banking, financial advisory, investment management, principal
investment, hedging, financing and brokerage activities. Certain of the underwriters and their respective affiliates have, from time to time, engaged, and may in the future engage in, various investment banking and other commercial dealings in the
ordinary course of business with us or our affiliates, for which they received or will receive customary fees and commissions. Certain affiliates of the underwriters for this offering are lenders under our revolving credit facility.

In the ordinary course of their various business activities, the underwriters and their respective affiliates may make or hold a broad array
of investments and actively trade debt and equity securities (or related derivative securities) and financial instruments (including bank loans) for their own account and for the accounts of their customers. Such investments and securities
activities may involve securities and/or instruments of ours or our affiliates. If any of the underwriters or their affiliates have a lending relationship with us, certain of those

S-29

underwriters or their affiliates routinely hedge, and certain other of those underwriters may hedge, their credit exposure to us